Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-20

Clinical Trial Update: Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

View source ↗

Summary

A completed clinical trial update reports patient- and clinician-reported outcomes on the effectiveness and safety of tirbanibulin for actinic keratosis, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirbanibulin (tirbanibulin)

Snippet

Sponsor: Almirall, S.A. | Conditions: Keratosis, Actinic | Status: COMPLETED | Results posted: 2024-09-20